Buprenorphine is used during pregnancy for the treatment of opioid use disorder. Limited
data exist on the central nervous system (CNS) permeation and distribution, and on the fetal …

Background Buprenorphine is used in the opioid maintenance treatment for opioid
dependent patients, including pregnant women. Despite the wide use, limited data exists on …

Buprenorphine is a semi‐synthetic opioid, widely used in the maintenance treatment for
opioid‐dependent pregnant women. Limited data exist on the pharmacokinetics of …

Background Buprenorphine is a Food and Drug Administration–approved maintenance
therapy for opioid use disorders and is increasingly being used in pregnant women with …

Background Buprenorphine, a partial opioid agonist used in treating opioid dependence, is
not approved in Australia for use in pregnancy. Nevertheless, many pregnant women …

Background The dosing regimen in the package insert for sublingual buprenorphine is
similar for pregnant and nonpregnant people despite the physiologic changes seen during …

Buprenorphine is approved as pharmacotherapy for opioid dependence in nonpregnant
patients in multiple countries and is currently under investigation for pregnant women in the …

Little is known about the safety of buprenorphine (BUP) in breastfeeding. The aim of this
work was to investigate the transfer of buprenorphine and its main active metabolite …

Background: Buprenorphine is currently under investigation as a pharmacotherapy to treat
pregnant women for opioid dependence. This research evaluates buprenorphine (BUP) …

Background Dose-adjusted plasma concentrations of buprenorphine are significantly
decreased during pregnancy compared with the nonpregnant state. This observation …